Takeda Gmbh

Matthias Mueller

Beate Schmidt

Andreas Pahl

Josef Stadlwieser

Torsten Dunkern

Heiko Bernsmann

Ewald Benediktus

Ragna Hussong

Olaf Nimz

The compounds of Formula (I), wherein R1, R2, R21, R22, R23, R24, Y and R3 have the meanings as given in the description, the salts thereof, the stereoisomers of the compounds and the salts thereof are effective inhibitors of the type 5 phosphodiesterase and are useful for treating or preventing idiopathic pulmonary lung fibrosis.

Methylpyrrolopyrimidinecarboxamides

The compounds of Formula (I), wherein R1, R2, R21, R22, R23, R24, Y and R3 have the meanings as given in the description, the salts thereof, the stereoisomers of the compounds and the salts thereof are effective inhibitors of the type 5 phosphodiesterase.

Growing community of inventors

Constance, Germany

Matthias Mueller